Board of Advisors
Advisor since 2021, Sitikantha Banerjee, M.D. is known for his expertise in the field of Global Health. Dr. Sitikantha is Assistant Professor, Community Medicine at All India Institute of Medical Sciences, Jammu, Jammu and Kashmir, Indi. His exceptional contributions have earned him a reputation as a valuable and well-respected team member.
In 2019, Dr. Sitikantha authored an important publication on the importance of Mass Drug Administration coverage in the elimination of Lymphatic Filariasis. This work emphasized the relevance of program strategies in India, including the incorporation of Ivermectin and the involvement of urban Accredited Social Health Activists. Dr. Sitikantha highlighted the preference for distributing drugs in blister packs to enhance acceptance among patients—an essential factor in achieving successful outcomes.
Dr. Sitikantha obtained his MD degree from Katwa KDI Medical School. At our nonprofit global health company, we recognize the immense value of Dr. Sitikantha’s expertise and consequently, we have plans to engage him in our studies investigating the use of blister packaging for triple therapy in the treatment of lymphatic filariasis in India. His valuable insights and experience will undoubtedly contribute to the success of these projects.
We are honored to have Dr. Sitikantha as an esteemed member of our team. His dedication to advancing global health initiatives and his notable achievements in the field of epidemiology make him an invaluable asset. Together, we strive to make significant progress in improving health outcomes and fostering a healthier future for all.